Providing Savings And Access For Biosimilars
Posted Wednesday, August 12, 2026Did You Know? As of December 2025, 85 biosimilars have been approved for use by the FDA.
Savings without Sacrificing Value
Matrix GPO helps make biosimilars financially viable, and CuraScript SD helps ensure members have reliable access.
01 | What Are Biosimilars
Biosimilars are medications that are highly similar to FDA-approved biologics with no clinically meaningful differences. Did you know, as of December 2025, 85 biosimilars have been approved by the FDA? The growing number of biosimilars underscores the continued expansion of this important treatment category. This evolving market underscores the importance of access, helping providers offer patients necessary therapies while supporting savings for both providers and patients.
02 | Providing Affordable Access
Matrix GPO members gain access to contracts and products at negotiated prices — including biosimilars — with eligibility for contract-based rebates, comprehensive account management, and ongoing membership support. Members may also benefit from advanced insights into performance, spending, and savings, along with value-added services, such as inventory management.
03 | More Choice. More Savings. More Access.
Each biosimilar that enters the market can help broaden patient access, improve affordability, and create meaningful savings opportunities for patients, providers, employers, and healthcare programs.
To support members who are looking to purchase biosimilars, our team offers support by helping to:
- Optimize purchasing strategies across biosimilars and specialty therapies
- Navigate contract considerations and cost structures
- Align product access with financial objectives
04 | Partnership with Specialty Distribution
Access to biosimilars is only part of the equation. Reliable specialty distribution is equally important. Matrix GPO has partnered with CuraScript SD, an Evernorth company, to provide continued support to our members through the distribution of biosimilars.
Both Matrix GPO and our partner provide members support with:
- Informed product selection
- Operational efficiency
- Financial sustainability
Learn More
Contact us today to learn more about the resources available to Matrix GPO members, how we support access to biosimilars, and how to become a member.
References
https://matrixgpo.com/Content/gpo-overview
https://www.centerforbiosimilars.com/biosimilar-approvals
https://www.evernorth.com/articles/pharmacy-focus-unlocking-promise-biosimilars
https://www.fda.gov/drugs/biosimilars/overview-health-care-professionals
2026